Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 161, Issue 6, Pages 821-831
Publisher
Wiley
Online
2013-04-18
DOI
10.1111/bjh.12333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma
- (2012) Walter M. T. Braga et al. Clinical & Developmental Immunology
- Emerging drugs for axial spondyloarthritis including ankylosing spondylitis
- (2012) Noemi Busquets-Perez et al. EXPERT OPINION ON EMERGING DRUGS
- Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors
- (2012) Iannis E Adamopoulos et al. ARTHRITIS RESEARCH & THERAPY
- Biologic Therapies for Spondyloarthritis: What Is New?
- (2012) Xenofon Baraliakos et al. Current Rheumatology Reports
- Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritis
- (2011) Marije I. Koenders et al. ARTHRITIS AND RHEUMATISM
- The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation
- (2011) Junichi Tsukada et al. CYTOKINE
- Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro
- (2011) Marco Tucci et al. EXPERIMENTAL HEMATOLOGY
- Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis
- (2011) Jeske J. Smink et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression?
- (2011) M. Tucci et al. ONCOLOGIST
- A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
- (2010) K. Noonan et al. BLOOD
- Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
- (2010) R. H. Prabhala et al. BLOOD
- IL-17-Mediated Monocyte Migration Occurs Partially through CC Chemokine Ligand 2/Monocyte Chemoattractant Protein-1 Induction
- (2010) S. Shahrara et al. JOURNAL OF IMMUNOLOGY
- Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease
- (2009) A. Kukreja et al. BLOOD
- Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
- (2009) Dharminder Chauhan et al. CANCER CELL
- Transcription factor C/EBPβ isoform ratio regulates osteoclastogenesis through MafB
- (2009) Jeske J Smink et al. EMBO JOURNAL
- Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes
- (2009) A Gallois et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of RANK Expression and Osteoclastogenesis by TLRs and IFN- in Human Osteoclast Precursors
- (2009) J.-D. Ji et al. JOURNAL OF IMMUNOLOGY
- Rapamycin and the transcription factor C/EBPβ as a switch in osteoclast differentiation: implications for lytic bone diseases
- (2009) Jeske J. Smink et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts
- (2008) A. Wakkach et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started